Outlook:
With the opening of the important EU market and continued growth in usage across all regions and Food and Beverage categories including major CSD brands we remain confident of the long term future of high purity stevia. The success of our expanded product portfolio and our continued customer acquisition supports our confidence in PureCircle's leading role in that future.
We do not however expect to see rapid sales growth until CY 2013 and CY 2014 when the combination of EU approval, the launches of major stevia sweetened CSDs and the unwinding of BGKA's inventories take fuller effect.
Our business model is sensitive to sales volumes. Whilst sales remain modest relative to our supply chain capacity, our margins too will remain substantially below those of our long term business model.
Looking at FY12, we expect H2 to show much stronger revenues than H1. However with BGKA demand tracking later than expected this is likely to impact FY 13 and FY 14 revenues not FY 12. Accordingly our sales guidance for H2 FY12 is in the range of $30m to $50m.
Entscheidend für mich ist die Aussage in diesem Outlook:
...vor 2013/2014 sehen wir keine rapide steigenden Verkaufszahlen....
Es kommt alles nicht so schnell in Bewegung, wie erhofft, man ist sich aber der erfolgreichen Zukunft bewußt!
-----------
Wir werden sehen, sprach der Blinde!
Carpe diem! |
, schweige ich lieber ...
